Objective: Cervical cancer is the 2nd most common cancer in Indonesia. Screening techniques can detect precancerous lesions, but direct visual inspection with acetic acid (VIA) can be subjective. Smartphones may assist healthcare providers in improving interpretation. This study aim to compare the accuracy of direct VIA, smartphone VIA (S-VIA) with 8-MP and 12-MP cameras, Pap smear, and biopsy in cervical cancer screening. Material and Methods: This cross-sectional diagnostic study follows the standards for the reporting of diagnostic accuracy studies (STARD 2015) guidelines. Each participant underwent screening and those with abnormal results proceeded to biopsy. The study included women aged 20-60 years who participated in the early detection cervical cancer program by the Yogyakarta Health Government from April to October 2017. Result: The study included 174 participants. Both direct VIA and S-VIA demonstrated low sensitivity but high specificity compared to the Pap smear. Direct VIA showed the highest accuracy relative to the Pap smear and the highest sensitivity to biopsy (100%), while the Pap smear had the highest specificity to biopsy (86.36%). The positive predictive values were low, whereas the negative predictive values were high. Direct VIA exhibited the highest positive likelihood ratio and the lowest negative likelihood ratio. The highest accuracy relative to biopsy was observed with the Pap smear, followed by direct VIA, S-VIA 12-MP, and S-VIA 8-MP. Conclusion: The highest accuracy was obtained from the Pap smear. VIA showed superior sensitivity and comparable specificity to the Pap smear. S-VIA with smartphone cameras offers a convenient alternative. Biopsy confirmation remains essential for accurate diagnosis and proper management.
Keywords: Cervical cancer; Pap smear; direct VIA; low-resource setting; smartphone-based VIA
Amaç: Serviks kanseri, Endonezya'da en sık görülen ikinci kanserdir. Tarama yöntemleri prekanseröz lezyonları tespit edebilse de, asetik asit ile doğrudan görsel inceleme (VIA) öznel olabilmektedir. Akıllı telefonlar, sağlık çalışanlarının yorumlama becerilerini geliştirmelerine yardımcı olabilir. Bu çalışmanın amacı, serviks kanseri taramasında doğrudan VIA, 8 MP ve 12 MP kameralarla akıllı telefon VIA (S-VIA), Pap smear ve biyopsinin doğruluğunu karşılaştırmaktır. Gereç ve Yöntemler: Bu kesitsel tanısal çalışma, STARD 2015 kılavuzlarına uygun olarak yürütülmüştür. Her katılımcıya tarama yapılmış ve anormal sonuç saptananlara biyopsi uygulanmıştır. Çalışmaya, Nisan-Ekim 2017 tarihleri arasında Yogyakarta Sağlık Müdürlüğü tarafından yürütülen serviks kanseri erken tanı programına katılan, 20-60 yaş arası kadınlar dâhil edilmiştir. Bulgular: Çalışmaya 174 katılımcı dâhil edilmiştir. Hem doğrudan VIA hem de S-VIA, Pap smear ile karşılaştırıldığında düşük duyarlılık ancak yüksek özgüllük göstermiştir. Doğrudan VIA, Pap smear'e kıyasla en yüksek doğruluğu ve biyopsiye karşı en yüksek duyarlılığı (%100) ortaya koyarken, Pap smear biyopsiye karşı en yüksek özgüllüğe (%86,36) sahip olmuştur. Pozitif prediktif değerler (PPV) düşük, negatif prediktif değerler (NPV) ise yüksek bulunmuştur. Doğrudan VIA, en yüksek pozitif olasılık oranını (LR+) ve en düşük negatif olasılık oranını (LR-) sergilemiştir. Biyopsi ile karşılaştırıldığında en yüksek doğruluk Pap smear'de görülmüş, bunu sırasıyla doğrudan VIA, 12 MP S-VIA ve 8 MP S-VIA izlemiştir. Sonuç: En yüksek doğruluk Pap smear ile elde edilmiştir. VIA, Pap smear'e kıyasla üstün duyarlılık ve benzer özgüllük göstermiştir. Akıllı telefon kameraları ile yapılan S-VIA pratik bir alternatif sunmaktadır. Bununla birlikte, doğru tanı ve uygun yönetim için biyopsi doğrulaması temel önem taşımaktadır.
Anahtar Kelimeler: Serviks kanseri; Pap smear; doğrudan VIA; kaynak kısıtlı ortam; akıllı telefon destekli VIA
- Fowler JR, Maani EV, Dunton CJ, Gasalberti DP, Jack BW. Cervical Cancer. [Updated 2023 Nov 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: [Link]
- World Health Organization [Internet]. © 2025 WHO [Cited January 15, 2024]. Cervical cancer. Available from: [Link]
- Habtemariam LW, Zewde ET, Simegn GL. Cervix type and cervical cancer classification system using deep learning techniques. Med Devices (Auckl). 2022;15:163-76. [PubMed] [PMC]
- Kementerian Kesehatan Republik Indonesia. Globocan 2020 dalam Kebijakan Penanggulangan Kanker Leher Rahim di Indonesia. Jakarta: Kementerian Kesehatan; 2023. [Link]
- Schiffman M, Doorbar J, Wentzensen N, de Sanjosé S, Fakhry C, Monk BJ, et al. Carcinogenic human papillomavirus infection. Nat Rev Dis Primers. 2016;2:16086. [PubMed]
- Banerjee D, Mittal S, Mandal R, Basu P. Screening technologies for cervical cancer: overview. Cytojournal. 2022;19:23. [Crossref] [PubMed] [PMC]
- Casas CPR, Albuquerque RCR, Loureiro RB, Gollner AM, Freitas MG, Duque GPDN, et al. Cervical cancer screening in low- and middle-income countries: a systematic review of economic evaluation studies. Clinics (Sao Paulo). 2022;77:100080. [PubMed] [PMC]
- Poli UR, Bidinger PD, Gowrishankar S. Visual inspection with acetic acid (VIA) screening program: 7 years experience in early detection of cervical cancer and pre-cancers in rural South India. Indian J Community Med. 2015;40(3):203-7. [Crossref] [PubMed] [PMC]
- Cubie HA, Campbell C. Cervical cancer screening-the challenges of complete pathways of care in low-income countries: focus on Malawi. Womens Health (Lond). 2020;16:1745506520914804. [Crossref] [PubMed] [PMC]
- Sami J, Lemoupa Makajio S, Jeannot E, Kenfack B, Viñals R, Vassilakos P, et al. Smartphone-based visual inspection with acetic acid: an innovative tool to improve cervical cancer screening in low-resource setting. Healthcare (Basel). 2022;10(2):391. [Crossref] [PubMed] [PMC]
- Freedman LS. Tables of the number of patients required in clinical trials using the logrank test. Stat Med. 1982;1(2):121-9. [Crossref] [PubMed]
- Catarino R, Vassilakos P, Scaringella S, Undurraga-Malinverno M, Meyer-Hamme U, Ricard-Gauthier D, et al. Smartphone use for cervical cancer screening in low-resource countries: a pilot study conducted in Madagascar. PLoS One. 2015;10(7):e0134309. [Crossref] [PubMed] [PMC]
- World Health Organization [Internet]. © 2025 WHO [Cited: February 1, 2024]. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Available from: [Link]
- Kementerian Kesehatan Republik Indonesia [Internet]. Rencana Aksi Nasional Eliminasi Kanker Leher Rahim di Indonesia 2023-2030. Jakarta: Kementerian Kesehatan; 2024. [Cited: February 1, 2024]. Available from: [Link]
- Wahidin M, Febrianti R, Susanty F, Hasanah SR. Twelve years implementation of cervical and breast cancer screening program in Indonesia. Asian Pac J Cancer Prev. 2022;23(3):829-37. [Crossref] [PubMed] [PMC]
- Himpunan Onkologi Ginekologi Indonesia [Internet]. P.O.G.I [Cited: January 15, 2024]. Skrining kanker serviks dan tindak lanjut temuan abnormal. Available from: [Link]
- Sharma P, Pattanshetty SM. A study on risk factors of cervical cancer among patients attending a tertiary care hospital: a case-control study. Clin Epidemiol Glob Health. 2018;6(2):83-7. [Crossref] [PubMed]
- Mekonnen AG, Mittiku YM. Early-onset of sexual activity as a potential risk of cervical cancer in Africa: a review of literature. PLOS Glob Public Health. 2023;3(3):e0000941. [Crossref] [PubMed] [PMC]
- Tekalegn Y, Sahiledengle B, Woldeyohannes D, Atlaw D, Degno S, Desta F, et al. High parity is associated with increased risk of cervical cancer: systematic review and meta-analysis of case-control studies. Womens Health (Lond). 2022;18:17455065221075904. [Crossref] [PubMed] [PMC]
- Tonui P, Itsura P, Omenge O, Faiza N, Keter A, Mburu A, et al. Digital cervicography using mobile phones with real-time consultation (DCRC) to improve performance of visual inspection with acetic acid (VIA) in cervical cancer screening of HIV-infected women. A cross-sectional study. Gynecol Oncol Rep. 2024;57:101661. [PubMed] [PMC]
- Ricard-Gauthier D, Wisniak A, Catarino R, van Rossum AF, Meyer-Hamme U, Negulescu R, et al. Use of smartphones as adjuvant tools for cervical cancer screening in low-resource settings. J Low Genit Tract Dis. 2015;19(4):295-300. [Crossref] [PubMed]
- Jeronimo J, Tsu V. Correspondence to ?evaluation of a cervicography-based program to ensure quality of visual inspection of the cervix in HIV-infected women in Johannesburg, South Africa?. J Low Genit Tract Dis. 2015;19(2):e46. [Crossref] [PubMed]
- Singhakum N, Laiwejpithaya S, Chaopotong P. Digital cervicography by simply portable device as an alternative test for cervical cancer screening in rural area of Thailand. Asian Pac J Cancer Prev. 2018;19(4):1145-9. [Crossref] [PubMed] [PMC]
.: Process List